Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atomoxetine for Methamphetamine Dependence
NCT01557569Phase 2Completed
- Sponsor
- University of Arkansas
- Start
- Apr 2012
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atomoxetine in methamphetamine use disorder (MUD), sponsored by University of Arkansas. Started Apr 2012; status: completed.
02
Drugs
atomoxetine
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on NCT01557569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01557569.